Yves Rival

Yves Rival is a notable inventor based in Lagarrigue, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on drug compounds. With a total of 3 patents to his name, Rival's inventions focus on the development of therapeutic agents.

Latest Patents

One of Yves Rival's latest patents is titled "Derivatives of benzothiazines, preparation thereof and application thereof as drugs." This invention involves benzothiazine derivatives that can inhibit 11β-HSD1 at both enzymatic and cellular levels. The compounds are characterized by a general formula where R can represent various chemical groups, including hydrogen, esters, and ethers.

Another significant patent is "Derivatives of triazines and uracils, their preparation and their application in human therapeutics." This invention relates to derivatives with a general formula that includes nitrogen and various alkyl radicals. The compounds are designed for potential therapeutic applications, showcasing Rival's commitment to advancing medical science.

Career Highlights

Yves Rival is currently associated with Pierre Fabre Medicament, a company known for its focus on healthcare and pharmaceuticals. His work at this institution has allowed him to explore innovative solutions in drug development, contributing to the advancement of therapeutic options available in the market.

Collaborations

Throughout his career, Yves Rival has collaborated with esteemed colleagues such as Didier Junquero and Elisabeth Dupont-Passelaigue. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Yves Rival's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to impact the development of new therapeutic agents, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.